vs
Side-by-side financial comparison of NB Bancorp, Inc. (NBBK) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $63.4M, roughly 1.2× NB Bancorp, Inc.). On growth, NB Bancorp, Inc. posted the faster year-over-year revenue change (33.9% vs 27.7%). NB Bancorp, Inc. produced more free cash flow last quarter ($57.4M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 22.6%).
NB Bancorp, Inc. is a U.S.-based bank holding company operating through its fully owned banking subsidiary. It provides a full range of retail and commercial banking services including various deposit products, consumer loans, residential mortgages, and small business financing solutions, primarily catering to individual and small-to-mid-sized enterprise customers across the New York metropolitan area.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
NBBK vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $63.4M | $75.5M |
| Net Profit | $7.7M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | 23.5% | 22.7% |
| Net Margin | 12.2% | — |
| Revenue YoY | 33.9% | 27.7% |
| Net Profit YoY | -50.6% | — |
| EPS (diluted) | $0.19 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $63.4M | $75.5M | ||
| Q3 25 | $51.7M | $54.5M | ||
| Q2 25 | $51.2M | $52.4M | ||
| Q1 25 | $47.4M | $46.0M | ||
| Q4 24 | $47.3M | $59.1M | ||
| Q3 24 | $42.6M | $80.5M | ||
| Q2 24 | $41.7M | $47.1M | ||
| Q1 24 | $42.1M | $43.8M |
| Q4 25 | $7.7M | — | ||
| Q3 25 | $15.4M | $8.8M | ||
| Q2 25 | $14.6M | $5.9M | ||
| Q1 25 | $12.7M | $3.0M | ||
| Q4 24 | $15.6M | — | ||
| Q3 24 | $8.4M | $20.3M | ||
| Q2 24 | $9.5M | $-4.5M | ||
| Q1 24 | $8.7M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | 23.5% | 22.7% | ||
| Q3 25 | 38.6% | 17.6% | ||
| Q2 25 | 36.6% | 12.7% | ||
| Q1 25 | 37.1% | 8.7% | ||
| Q4 24 | 40.7% | 22.6% | ||
| Q3 24 | 36.1% | 27.4% | ||
| Q2 24 | 28.3% | -4.6% | ||
| Q1 24 | 28.8% | -5.3% |
| Q4 25 | 12.2% | — | ||
| Q3 25 | 29.7% | 16.2% | ||
| Q2 25 | 28.5% | 11.2% | ||
| Q1 25 | 26.7% | 6.5% | ||
| Q4 24 | 33.0% | — | ||
| Q3 24 | 19.7% | 25.2% | ||
| Q2 24 | 22.7% | -9.6% | ||
| Q1 24 | 20.7% | -11.0% |
| Q4 25 | $0.19 | $0.26 | ||
| Q3 25 | $0.43 | $0.17 | ||
| Q2 25 | $0.39 | $0.12 | ||
| Q1 25 | $0.33 | $0.06 | ||
| Q4 24 | $0.40 | $0.40 | ||
| Q3 24 | $0.21 | $0.41 | ||
| Q2 24 | $0.24 | $-0.09 | ||
| Q1 24 | $0.22 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $858.9M | $130.3M |
| Total Assets | $7.0B | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $858.9M | $130.3M | ||
| Q3 25 | $737.0M | $115.3M | ||
| Q2 25 | $737.1M | $104.7M | ||
| Q1 25 | $739.6M | $97.1M | ||
| Q4 24 | $765.2M | $92.1M | ||
| Q3 24 | $747.4M | $71.1M | ||
| Q2 24 | $734.3M | $48.5M | ||
| Q1 24 | $733.8M | $51.0M |
| Q4 25 | $7.0B | $216.3M | ||
| Q3 25 | $5.4B | $202.9M | ||
| Q2 25 | $5.2B | $194.9M | ||
| Q1 25 | $5.2B | $196.2M | ||
| Q4 24 | $5.2B | $213.3M | ||
| Q3 24 | $5.0B | $220.7M | ||
| Q2 24 | $4.8B | $205.0M | ||
| Q1 24 | $4.7B | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $60.8M | $14.4M |
| Free Cash FlowOCF − Capex | $57.4M | $14.4M |
| FCF MarginFCF / Revenue | 90.6% | 19.1% |
| Capex IntensityCapex / Revenue | 5.4% | 0.0% |
| Cash ConversionOCF / Net Profit | 7.89× | — |
| TTM Free Cash FlowTrailing 4 quarters | $117.2M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $60.8M | $14.4M | ||
| Q3 25 | $24.2M | $9.7M | ||
| Q2 25 | $27.0M | $14.1M | ||
| Q1 25 | $9.9M | $3.6M | ||
| Q4 24 | $43.2M | $15.6M | ||
| Q3 24 | $8.6M | $11.0M | ||
| Q2 24 | $24.7M | $1.0M | ||
| Q1 24 | $-11.4M | $11.2M |
| Q4 25 | $57.4M | $14.4M | ||
| Q3 25 | $23.9M | $9.7M | ||
| Q2 25 | $26.1M | $14.1M | ||
| Q1 25 | $9.8M | $3.6M | ||
| Q4 24 | $41.3M | $15.6M | ||
| Q3 24 | $8.4M | $11.0M | ||
| Q2 24 | $23.8M | $1.0M | ||
| Q1 24 | $-11.7M | — |
| Q4 25 | 90.6% | 19.1% | ||
| Q3 25 | 46.3% | 17.7% | ||
| Q2 25 | 51.0% | 26.8% | ||
| Q1 25 | 20.8% | 7.7% | ||
| Q4 24 | 87.2% | 26.4% | ||
| Q3 24 | 19.7% | 13.7% | ||
| Q2 24 | 57.1% | 2.1% | ||
| Q1 24 | -27.7% | — |
| Q4 25 | 5.4% | 0.0% | ||
| Q3 25 | 0.6% | 0.0% | ||
| Q2 25 | 1.9% | 0.0% | ||
| Q1 25 | 0.2% | 0.1% | ||
| Q4 24 | 4.1% | 0.0% | ||
| Q3 24 | 0.5% | 0.0% | ||
| Q2 24 | 2.1% | 0.0% | ||
| Q1 24 | 0.6% | 0.0% |
| Q4 25 | 7.89× | — | ||
| Q3 25 | 1.58× | 1.10× | ||
| Q2 25 | 1.85× | 2.41× | ||
| Q1 25 | 0.79× | 1.21× | ||
| Q4 24 | 2.77× | — | ||
| Q3 24 | 1.03× | 0.54× | ||
| Q2 24 | 2.61× | — | ||
| Q1 24 | -1.31× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
